Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2007
08/23/2007US20070197570 Indanol derivative
08/23/2007US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome
08/23/2007US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone
08/23/2007US20070197519 New Process For The Preparation Of Oxabispidines
08/23/2007US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient
08/23/2007US20070197499 Pharmaceutical compounds
08/23/2007US20070197476 Triptolide Derivatives And Their Uses
08/23/2007US20070197456 Preparation and diabetic use of Gibberellins
08/23/2007US20070197450 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
08/23/2007US20070197449 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
08/23/2007US20070196857 Determination of risk and treatment of complications of prematurity
08/23/2007US20070196480 Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof
08/23/2007US20070196379 Methods for treating congestive heart failure
08/23/2007US20070196370 Type 2 cytokine receptor and nucleic acids encoding same
08/23/2007US20070196347 Methods for preventing neurological events
08/23/2007US20070196331 Methods and compositions for mobilizing stem cells
08/23/2007DE20023910U1 Pharmakologisch wirksame Substanz zur Behandlung kardiovasulärer Erkrankungen Pharmacologically active substance for treating diseases kardiovasulärer
08/23/2007CA2645734A1 Method of treating inflammatory diseases
08/23/2007CA2642539A1 Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function
08/23/2007CA2642537A1 Vasodilator
08/23/2007CA2642239A1 Drug combinations for the treatment of respiratory tract diseases
08/23/2007CA2642212A1 Novel tricyclic dihydropyrazines as potassium channel openers
08/23/2007CA2638787A1 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension
08/22/2007EP1820861A2 C3B/C4B complement receptor-like molecules and uses thereof
08/22/2007EP1820854A2 JNK3 modulators and methods of use
08/22/2007EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
08/22/2007EP1820495A2 Microspheres for active embolization
08/22/2007EP1820442A1 Noninvasive measurements of chemical substances
08/22/2007EP1819704A1 Pyrrolopyridine-2-carboxylic acid amide derivative useful as inhibitor of glycogen phosphorylase
08/22/2007EP1819675A1 5-amino-4-hydroxy-2-isopropyl-7-ý4-methoxy-3-(3-methoxypropxy)benzyl¨-8-methylnonanamides
08/22/2007EP1819355A2 Methods of using chimeric coiled-coil molecule
08/22/2007EP1819351A1 Poncirus trifoliata extract for preventing and treating ischemic heart diseases and phar^ maceutical composition and health food containing the same
08/22/2007EP1819330A1 5-carboxamido substitued thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family
08/22/2007EP1819227A1 Pharmaceutical formulation of decitabine
08/22/2007EP1572892A4 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
08/22/2007EP1567502B1 Substituted dihydrophenanthridinesul fonamides
08/22/2007EP1534807B1 A process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
08/22/2007EP1499320B1 Novel compounds
08/22/2007EP1490405B1 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
08/22/2007EP1467728B1 Pharmaceutical compositions comprising valsartan and nep inhibitors
08/22/2007EP1448523B1 Heterocyclic compounds and methods of use
08/22/2007EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
08/22/2007EP1359920B1 Uses of oral formulations for the treatment of female sexual dysfunction
08/22/2007EP1351673B1 Compositions of stable t3 and use thereof
08/22/2007EP1300399B1 Phenylpyridazine derivatives and drugs containing the same
08/22/2007EP1227813B1 REVERSE-TURN MIMETICS AS alpha 4ß INTEGRIN INHIBITORS
08/22/2007EP1227804B1 Use of eplerenone for treating restenosis
08/22/2007EP1178952B1 Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators
08/22/2007EP1157040B1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
08/22/2007EP1150970B1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/22/2007EP1124824B1 Chromenone and chromanone derivatives as integrin inhibitors
08/22/2007CN1332983C Polysaccharide of rhizoma corydalis, preparation method and application
08/22/2007CN1332977C Novel techykinin peptides, precursor peptides thereof and genes encoding the same
08/22/2007CN1332973C Extraction process of conjugated female hormone
08/22/2007CN1332971C Luteolin-7-O-bata-glucuronide and its extracting process and application thereof
08/22/2007CN1332969C Flavonoid glycoside compound and its preparing process
08/22/2007CN1332961C Inhibitors of alpha L beta 2 mediated cell adhesion
08/22/2007CN1332960C Imidazoquinoline derivatives as adenosine A3 receptor ligands
08/22/2007CN1332952C 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im
08/22/2007CN1332939C Novel compounds inhibiting factor Xa activity
08/22/2007CN1332933C Process for the synthesis of (is)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and uses thereof
08/22/2007CN1332714C Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist
08/22/2007CN1332691C Medication for treating cardiovascular diseases prepared from byproduct of solution from 'Huangjiang' in producing saponin
08/22/2007CN1332674C Method for preparing Chinese medicinal formulation of dog button
08/22/2007CN1332659C Indole-3-methanol and its dimer application in preparation of medicnie for preventing and treating bred blood vessel disease
08/22/2007CN1332655C Uses of targeted oxidative therapeutic formulation in arteriosclerosis
08/22/2007CN1332652C Cough suppressing drip pill and its preparation method
08/22/2007CN101023060A Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, their use as a medicament, and a medicament containing them
08/22/2007CN101022791A Compositions comprising nebivolol
08/22/2007CN101020714A Earthworm protein with function of lowering blood pressure and its prepn process
08/22/2007CN101020662A Compound 3,4-diaryl pyrazole and its prepn and medicinal use
08/22/2007CN101020065A Regulating function of MR-1 gene in myocardial hypertrophy
08/22/2007CN101020034A Prepn process of medicine for treating cerebral apoplexy and its sequela
08/22/2007CN101020028A Chinese medicine for treating cardiac and cerebral vascular diseases
08/22/2007CN101020008A Specific heart protecting herb tea prepn for preventing and treating acute viral myocarditis
08/22/2007CN101020006A Hypotensive health product
08/22/2007CN101019998A Medicine for treating anorectal diseases
08/22/2007CN101019987A Hypotensive health product
08/22/2007CN101019974A Chinese medicine capsule for treating coronary heart disease
08/22/2007CN101019951A Medicine composition containing gingko leaf extract and cape jasmine extract and its application
08/22/2007CN101019947A Health product for lowering blood pressure
08/22/2007CN101019926A Chinese medicine for treating cardiac and cerebral vascular diseases and its prepn process
08/22/2007CN101019910A Use of Lindelofia stylosa as one borage family plant in preparing medicine for treating anroectal diseases
08/22/2007CN101019909A Supercritical safflower extracting process
08/22/2007CN101019905A Medicine composition containing tribulus fruit furostanol saponin and its application
08/22/2007CN101019904A Notoginseng dripping pill for treating coronary heart disease
08/22/2007CN101019883A Compound coenzyme Q10 medicine prepn and its prepn process and application
08/22/2007CN101019882A Compound coenzyme Q10 medicine prepn and its prepn process and application
08/22/2007CN101019881A Compound coenzyme Q10 medicine prepn and its prepn process and application
08/22/2007CN101019879A Compound coenzyme Q10 medicine prepn and its prepn process and application
08/22/2007CN101019878A Injection medicine composite containing salvianolic acid A and its prepn
08/22/2007CN101019877A Soluble mangiferin clathrate and its prepn
08/22/2007CN101019873A Compound coenzyme Q10 medicine prepn and its prepn process and application
08/22/2007CN101019858A Medicine composition possessing vasodilation and beta1 receptor blocking effects
08/22/2007CN101019855A Compound coenzyme Q10 medicine prepn and its prepn process and application
08/22/2007CN101019849A Compound coenzyme Q10 medicine prepn and its prepn process and application
08/22/2007CN101019848A Application of ferricitras in preparation of medicine to prevent and treat angiosteosis
08/22/2007CN101019837A Ginnone ester dispersing table and its prepn
08/22/2007CN101019824A Oral medicine composition containing salvianolic acid and its prepn
08/22/2007CN101019677A Sugar-less buckwheat flavone beverage
1 ... 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 ... 1595